Growth hormone insensitivity: Pathophysiology, diagnosis, clinical variation and future perspectives

Martin O. Savage, Christine P. Burren, Joanne C. Blair, Kathryn (Katie) Woods, Louise Metherell, Adrian J L Clark, Cecilia Camacho-Hübner

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The study of genetic growth hormone (GH) insensitivity is an evolving field. GH insensitivity syndrome (GHIS), otherwise known as Laron syndrome, is a heterogeneous disorder. Biochemical features consist of severe insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) deficiency and elevated GH secretion. In a heterogeneous 'European' cohort of GHIS patients, features varied from classical to moderate abnormalities of phenotype and endocrine disturbance. A study of facial features within this series showed that a mild subgroup existed with normal facies, mild short stature and moderate biochemical abnormalities. Overlap with idiopathic short stature (ISS) exists, with heterozygous mutations of the GH receptor demonstrated to cause impaired growth. This 'partial' GHIS has not yet been defined endocrinologically. GH sensitivity, measured by IGF-I and IGFBP-3 responses in the IGF-I generation test, may reveal abnormalities in ISS, although it is likely that the dose of recombinant human GH and frequency of sampling in the test need to be modified.

Original languageEnglish (US)
Pages (from-to)32-35
Number of pages4
JournalHormone Research
Volume55
Issue numberSUPPL. 2
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Growth Hormone
Laron Syndrome
Insulin-Like Growth Factor I
Insulin-Like Growth Factor Binding Protein 3
Somatotropin Receptors
Protein Deficiency
Human Growth Hormone
Phenotype
Mutation
Growth

Keywords

  • Growth hormone
  • Growth hormone binding protein
  • Growth hormone insensitivity syndrome
  • Growth hormone receptor
  • Insulin-like growth factor I
  • Insulin-like growth hormone binding protein 3

ASJC Scopus subject areas

  • Endocrinology

Cite this

Savage, M. O., Burren, C. P., Blair, J. C., Woods, K. K., Metherell, L., Clark, A. J. L., & Camacho-Hübner, C. (2001). Growth hormone insensitivity: Pathophysiology, diagnosis, clinical variation and future perspectives. Hormone Research, 55(SUPPL. 2), 32-35. https://doi.org/10.1159/000063471

Growth hormone insensitivity : Pathophysiology, diagnosis, clinical variation and future perspectives. / Savage, Martin O.; Burren, Christine P.; Blair, Joanne C.; Woods, Kathryn (Katie); Metherell, Louise; Clark, Adrian J L; Camacho-Hübner, Cecilia.

In: Hormone Research, Vol. 55, No. SUPPL. 2, 2001, p. 32-35.

Research output: Contribution to journalArticle

Savage, MO, Burren, CP, Blair, JC, Woods, KK, Metherell, L, Clark, AJL & Camacho-Hübner, C 2001, 'Growth hormone insensitivity: Pathophysiology, diagnosis, clinical variation and future perspectives', Hormone Research, vol. 55, no. SUPPL. 2, pp. 32-35. https://doi.org/10.1159/000063471
Savage, Martin O. ; Burren, Christine P. ; Blair, Joanne C. ; Woods, Kathryn (Katie) ; Metherell, Louise ; Clark, Adrian J L ; Camacho-Hübner, Cecilia. / Growth hormone insensitivity : Pathophysiology, diagnosis, clinical variation and future perspectives. In: Hormone Research. 2001 ; Vol. 55, No. SUPPL. 2. pp. 32-35.
@article{b2c05f2f4ff4467c8c2748df2164f64c,
title = "Growth hormone insensitivity: Pathophysiology, diagnosis, clinical variation and future perspectives",
abstract = "The study of genetic growth hormone (GH) insensitivity is an evolving field. GH insensitivity syndrome (GHIS), otherwise known as Laron syndrome, is a heterogeneous disorder. Biochemical features consist of severe insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) deficiency and elevated GH secretion. In a heterogeneous 'European' cohort of GHIS patients, features varied from classical to moderate abnormalities of phenotype and endocrine disturbance. A study of facial features within this series showed that a mild subgroup existed with normal facies, mild short stature and moderate biochemical abnormalities. Overlap with idiopathic short stature (ISS) exists, with heterozygous mutations of the GH receptor demonstrated to cause impaired growth. This 'partial' GHIS has not yet been defined endocrinologically. GH sensitivity, measured by IGF-I and IGFBP-3 responses in the IGF-I generation test, may reveal abnormalities in ISS, although it is likely that the dose of recombinant human GH and frequency of sampling in the test need to be modified.",
keywords = "Growth hormone, Growth hormone binding protein, Growth hormone insensitivity syndrome, Growth hormone receptor, Insulin-like growth factor I, Insulin-like growth hormone binding protein 3",
author = "Savage, {Martin O.} and Burren, {Christine P.} and Blair, {Joanne C.} and Woods, {Kathryn (Katie)} and Louise Metherell and Clark, {Adrian J L} and Cecilia Camacho-H{\"u}bner",
year = "2001",
doi = "10.1159/000063471",
language = "English (US)",
volume = "55",
pages = "32--35",
journal = "Hormone Research in Paediatrics",
issn = "1663-2818",
publisher = "S. Karger AG",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Growth hormone insensitivity

T2 - Pathophysiology, diagnosis, clinical variation and future perspectives

AU - Savage, Martin O.

AU - Burren, Christine P.

AU - Blair, Joanne C.

AU - Woods, Kathryn (Katie)

AU - Metherell, Louise

AU - Clark, Adrian J L

AU - Camacho-Hübner, Cecilia

PY - 2001

Y1 - 2001

N2 - The study of genetic growth hormone (GH) insensitivity is an evolving field. GH insensitivity syndrome (GHIS), otherwise known as Laron syndrome, is a heterogeneous disorder. Biochemical features consist of severe insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) deficiency and elevated GH secretion. In a heterogeneous 'European' cohort of GHIS patients, features varied from classical to moderate abnormalities of phenotype and endocrine disturbance. A study of facial features within this series showed that a mild subgroup existed with normal facies, mild short stature and moderate biochemical abnormalities. Overlap with idiopathic short stature (ISS) exists, with heterozygous mutations of the GH receptor demonstrated to cause impaired growth. This 'partial' GHIS has not yet been defined endocrinologically. GH sensitivity, measured by IGF-I and IGFBP-3 responses in the IGF-I generation test, may reveal abnormalities in ISS, although it is likely that the dose of recombinant human GH and frequency of sampling in the test need to be modified.

AB - The study of genetic growth hormone (GH) insensitivity is an evolving field. GH insensitivity syndrome (GHIS), otherwise known as Laron syndrome, is a heterogeneous disorder. Biochemical features consist of severe insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) deficiency and elevated GH secretion. In a heterogeneous 'European' cohort of GHIS patients, features varied from classical to moderate abnormalities of phenotype and endocrine disturbance. A study of facial features within this series showed that a mild subgroup existed with normal facies, mild short stature and moderate biochemical abnormalities. Overlap with idiopathic short stature (ISS) exists, with heterozygous mutations of the GH receptor demonstrated to cause impaired growth. This 'partial' GHIS has not yet been defined endocrinologically. GH sensitivity, measured by IGF-I and IGFBP-3 responses in the IGF-I generation test, may reveal abnormalities in ISS, although it is likely that the dose of recombinant human GH and frequency of sampling in the test need to be modified.

KW - Growth hormone

KW - Growth hormone binding protein

KW - Growth hormone insensitivity syndrome

KW - Growth hormone receptor

KW - Insulin-like growth factor I

KW - Insulin-like growth hormone binding protein 3

UR - http://www.scopus.com/inward/record.url?scp=0035742079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035742079&partnerID=8YFLogxK

U2 - 10.1159/000063471

DO - 10.1159/000063471

M3 - Article

C2 - 11684873

AN - SCOPUS:0035742079

VL - 55

SP - 32

EP - 35

JO - Hormone Research in Paediatrics

JF - Hormone Research in Paediatrics

SN - 1663-2818

IS - SUPPL. 2

ER -